Skip to content

Effect of Probiotics on blood lipid profile

Effect of probiotic b-activ on coronary heart disease risk profile

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/06/007026
Enrollment
100
Registered
2016-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Lactobacillus acidophilus LA5, Bifidobacteria bacterium BB12 and inulin in the form of curd: Marketed by Mother Dairy by Name- Probiotic b-activ Dosage- 400 g/day daily Mode of administ

Sponsors

Dr Seema Puri
Lead Sponsor
Ms Smriti Sharma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adults, males and females, 40-65 years of age Subjects having Total cholesterol levels >210 mg/dl and LDL- cholesterol levels >110 mg/dl Subjects who are willing to participate

Exclusion criteria

Exclusion criteria: Subjects having any chronic diseases and metabolic complications such as CVD, diabetes mellitus, renal, hepatic or pulmonary disease, myocardial infarction or undergone bypass surgery etc. Those on medication of hypolipidemic drugs and/ or functional foods such as plant sterols, oats fibre and other such supplements designed for serum lipid reduction Adults on antibiotic treatment in past 15days Subjects with hypersensitivity to dairy products Adolescents, pregnant and nursing women Subjects already on probiotic supplementation History of chronic use of alcohol Subjects with Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Total Cholesterol LDL-cholesterol Triglycerides HDL-cholesterolTimepoint: After Run-in, Week 0 After Trial, Week 8

Secondary

MeasureTime frame
BMI, Waist Circumference, Hip Circumference, Body Fat percent, Blood Pressure, Dietary Intake, Level of physical activity, Compliance of product, Stress level, medication if anyTimepoint: All after Run-in, Week 0 Compliance, medication if any at weekly intervals All after trial, Week 8

Countries

India

Contacts

Public ContactSmriti Sharma

Institute of Home Economics

smritivatsa@gmail.com9810003220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026